SMI
11.871,32
PKT
-0,20
PKT
±0,00
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.07.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 24.07.17 | Givaudan Neutral | UBS AG | |
| 24.07.17 | Novartis buy | Jefferies & Company Inc. | |
| 21.07.17 | Givaudan buy | Baader Bank | |
| 21.07.17 | Givaudan Neutral | BNP PARIBAS | |
| 21.07.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 21.07.17 | Givaudan overweight | JP Morgan Chase & Co. | |
| 21.07.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 21.07.17 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 21.07.17 | Swiss Re overweight | Morgan Stanley | |
| 21.07.17 | ABB (Asea Brown Boveri) Hold | Kepler Cheuvreux | |
| 21.07.17 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 21.07.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 21.07.17 | Givaudan Hold | Deutsche Bank AG | |
| 21.07.17 | Givaudan verkaufen | Bernstein Research | |
| 20.07.17 | Roche overweight | JP Morgan Chase & Co. | |
| 20.07.17 | UBS buy | Deutsche Bank AG | |
| 20.07.17 | UBS Hold | Deutsche Bank AG | |
| 20.07.17 | Holcim Hold | Deutsche Bank AG | |
| 20.07.17 | ABB (Asea Brown Boveri) Hold | S&P Capital IQ | |
| 20.07.17 | Novartis Neutral | UBS AG | |
| 20.07.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.07.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.07.17 | UBS buy | UBS AG | |
| 19.07.17 | Novartis Outperform | Bernstein Research | |
| 19.07.17 | Novartis buy | Société Générale Group S.A. (SG) | |
| 19.07.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 19.07.17 | Holcim Hold | Deutsche Bank AG | |
| 19.07.17 | Novartis Hold | Deutsche Bank AG | |
| 18.07.17 | Novartis Outperform | Bernstein Research | |
| 18.07.17 | Roche Outperform | Bernstein Research | |
| 18.07.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 18.07.17 | UBS overweight | Morgan Stanley | |
| 18.07.17 | UBS overweight | Morgan Stanley | |
| 18.07.17 | Novartis Hold | S&P Capital IQ | |
| 18.07.17 | Novartis Neutral | UBS AG | |
| 17.07.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 17.07.17 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.07.17 | Roche overweight | JP Morgan Chase & Co. | |
| 14.07.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.